SYUT Depositi SEC - Synutra International, Inc.- Relazione annuale, dichiarazione di delega, prospetto informativo

Statistiche di base

CIK

1293593

SEC Filings

All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis. These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to Synutra International, Inc.

SEC Filings (Chronological Order)

Questa pagina fornisce un elenco completo e cronologico dei depositi SEC, esclusi i documenti di proprietà che forniamo altrove.

May 25, 2017	15-12B	Synutra International FORM 15-12B UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 15 Certification and Notice of Termination of Registration Under Section 12(g) of the Securities Exchange Act of 1934 or Suspension of Duty to File Reports Under Sections 13 and 15(d) of the Securities Exchange Act of 1934 Commission File Number 001-33397 SYNUTRA INTERNATIONAL, INC. (Exact name of registrant as specified
May 16, 2017	EX-3.2	AMENDED AND RESTATED BYLAWS OF SYNUTRA INTERNATIONAL, INC. * * * * * Article 1 Offices EX-3.2 3 t1701578ex3-2.htm EXHIBIT 3.2 Exhibit 3.2 AMENDED AND RESTATED BYLAWS OF SYNUTRA INTERNATIONAL, INC. * * * * * Article 1 Offices Section 1.01. Registered Office. The registered office of the Corporation shall be in the City of Wilmington, County of New Castle, State of Delaware. Section 1.02. Other Offices. The Corporation may also have offices at such other places both within and without
May 16, 2017	EX-3.1	AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF SYNUTRA INTERNATIONAL, INC. EX-3.1 2 t1701578ex3-1.htm EXHIBIT 3.1 Exhibit 3.1 AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF SYNUTRA INTERNATIONAL, INC. FIRST: The name of the corporation is Synutra International, Inc. (the “Corporation”). SECOND: The address of its registered office in the State of Delaware is c/o The Corporation Trust Company, 1209 Orange Street, Wilmington, New Castle County, Delaware 19801. The na
May 16, 2017	EX-99.1	Synutra Announces Completion of Merger EX-99.1 4 t1701578ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 Synutra Announces Completion of Merger Qingdao, China and Rockville, Md. – May 16, 2017 – Synutra International, Inc. (Nasdaq: SYUT), (“Synutra” or the “Company”), which owns subsidiaries in China that produce, distribute and sell nutritional products for infants, children and adults, today announced the completion of the merger (the “Merger”)
May 16, 2017	8-K	Changes in Control of Registrant, Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Material Modification to Rights of Security Holders, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and Exhibits, Completion of Acquisition or Disposition of Assets, Other Events 8-K 1 t17015788k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): May 15, 2017 SYNUTRA INTERNATIONAL, INC. (Exact Name of Registrant as Specified in Charter) Delaware 001-33397 13-4306188 (State or Other Jurisdiction of I
May 16, 2017	SC 13D/A	SYUT / Synutra International, Inc. / Zhang Liang - FORM SC 13D/A Activist Investment SC 13D/A 1 dp76171sc13da7.htm FORM SC 13D/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A UNDER SECURITIES EXCHANGE ACT OF 1934 (Amendment No. 7)* SYNUTRA INTERNATIONAL, INC. (Name of Issuer) Common Stock, Par Value US$0.0001 Per Share (Title of Class of Securities) 87164C 10 2 (CUSIP Number) Liang Zhang 103 Dong Lu Yuan Tongzhou District, Beijing 101101 Pe
May 16, 2017	SC 13E3/A	SYUT / Synutra International, Inc. / Synutra International, Inc. - AMENDMENT NO. 3 TO SCHEDULE 13E-3 TABLE OF CONTENTS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13E-3 (Amendment No. 3) (Rule 13e-100) TRANSACTION STATEMENT UNDER SECTION 13(e) OF THE SECURITIES EXCHANGE ACT OF 1934 AND RULE 13e-3 THEREUNDER RULE 13e-3 Transaction Statement Under Section 13(e) of the Securities Exchange Act of 1934 Synutra International, Inc. (Name of the Issuer) Synutra Intern
April 28, 2017	EX-99.1	Synutra International Inc. Stockholders Vote to Approve Merger EX-99.1 2 t1701337ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 FOR IMMEDIATE RELEASE: Synutra International Inc. Stockholders Vote to Approve Merger Qingdao, China and Rockville, Md. – April 28, 2017 – Synutra International, Inc. (Nasdaq: SYUT), (“Synutra” or the “Company”), which owns subsidiaries in China that produce, distribute and sell nutritional products for infants, children and adults, today anno
April 28, 2017	8-K	Submission of Matters to a Vote of Security Holders, Other Events, Financial Statements and Exhibits 8-K 1 t17013378k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): April 28, 2017 SYNUTRA INTERNATIONAL, INC. (Exact Name of Registrant as Specified in Charter) Delaware 001-33397 13-4306188 (State or Other Jurisdiction of
April 18, 2017	8-K	Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): April 18, 2017 SYNUTRA INTERNATIONAL, INC.
April 18, 2017	EX-99.1	Three Leading Proxy Advisory Firms Recommend Synutra International Stockholders Vote “FOR” Proposed Going Private Transaction at $6.05 per Share in Cash Exhibit 99.1 FOR IMMEDIATE RELEASE: Three Leading Proxy Advisory Firms Recommend Synutra International Stockholders Vote ?FOR? Proposed Going Private Transaction at $6.05 per Share in Cash Qingdao, China and Rockville, Md. ? April 18, 2017 ? Synutra International, Inc. (Nasdaq: SYUT), (?Synutra? or the ?Company?), which owns subsidiaries in China that produce, distribute and sell nutritional produ
April 18, 2017	EX-99.1	Three Leading Proxy Advisory Firms Recommend Synutra International Stockholders Vote “FOR” Proposed Going Private Transaction at $6.05 per Share in Cash Exhibit 99.1 FOR IMMEDIATE RELEASE: Three Leading Proxy Advisory Firms Recommend Synutra International Stockholders Vote ?FOR? Proposed Going Private Transaction at $6.05 per Share in Cash Qingdao, China and Rockville, Md. ? April 18, 2017 ? Synutra International, Inc. (Nasdaq: SYUT), (?Synutra? or the ?Company?), which owns subsidiaries in China that produce, distribute and sell nutritional produ
April 18, 2017	DEFA14A	Synutra International FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): April 18, 2017 SYNUTRA INTERNATIONAL, INC.
April 7, 2017	DEFA14A	Synutra International DEFINITIVE ADDITIONAL MATERIALS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant x Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? Definitive Proxy State
March 30, 2017	DEFA14A	Synutra International DEFINITIVE ADDITIONAL MATERIALS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant x Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? Definitive Proxy State
March 20, 2017	8-K	Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): March 17, 2017 SYNUTRA INTERNATIONAL, INC.
March 13, 2017	8-K	Other Events, Financial Statements and Exhibits 8-K 1 t17007238k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): March 13, 2017 SYNUTRA INTERNATIONAL, INC. (Exact Name of Registrant as Specified in Charter) Delaware 001-33397 13-4306188 (State or Other Jurisdiction of
March 13, 2017	EX-99.1	Synutra Announces Record Date and Meeting Date for Special Meeting of Stockholders EX-99.1 2 t1700723ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 FOR IMMEDIATE RELEASE: Synutra Announces Record Date and Meeting Date for Special Meeting of Stockholders Qingdao, China and Rockville, Md. – March 13, 2017 – Synutra International, Inc. (Nasdaq: SYUT), (“Synutra” or the “Company”), which owns subsidiaries in China that produce, distribute and sell nutritional products for infants, children an
March 13, 2017	EX-99.1	Synutra Announces Record Date and Meeting Date for Special Meeting of Stockholders EX-99.1 2 t1700723ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 FOR IMMEDIATE RELEASE: Synutra Announces Record Date and Meeting Date for Special Meeting of Stockholders Qingdao, China and Rockville, Md. – March 13, 2017 – Synutra International, Inc. (Nasdaq: SYUT), (“Synutra” or the “Company”), which owns subsidiaries in China that produce, distribute and sell nutritional products for infants, children an
March 13, 2017	DEFA14A	Synutra International FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): March 13, 2017 SYNUTRA INTERNATIONAL, INC.
March 9, 2017	DEFA14A	Synutra International DEFINITIVE ADDITIONAL MATERIALS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant x Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? Definitive Proxy State
March 9, 2017	DEFM14A	Synutra International DEFINITIVE PROXY STATEMENT t1700203-defm14a - block - 14.8274826s TABLE OF CONTENTS ? ? UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (RULE 14a-101) SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant?? Filed by a Party other than the Registrant?? Check the appropriate box: ? Preliminary Proxy Statement. ? ?
March 9, 2017	SC 13E3/A	SYUT / Synutra International, Inc. / Synutra International, Inc. - AMENDMENT NO.2 TO SCHEDULE 13E3 SC 13E3/A 1 t1700534sc13e3a.htm AMENDMENT NO.2 TO SCHEDULE 13E3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13E-3 (Amendment No. 2) (Rule 13e-100) TRANSACTION STATEMENT UNDER SECTION 13(e) OF THE SECURITIES EXCHANGE ACT OF 1934 AND RULE 13e-3 THEREUNDER RULE 13e-3 Transaction Statement Under Section 13(e) of the Securities Exchange Act of 1934 Synutra Internati
February 9, 2017	EX-99.1	Synutra Reports Third Quarter Fiscal 2017 Financial Results ~3Q17 Net Sales of $109.1 million ~3Q17 Nutritional Food sales of $98.0 million Exhibit 99.1 FOR IMMEDIATE RELEASE: Synutra Reports Third Quarter Fiscal 2017 Financial Results ~3Q17 Net Sales of $109.1 million ~3Q17 Nutritional Food sales of $98.0 million Qingdao, China and Rockville, Md. ? February 9, 2017 ? Synutra International, Inc. (Nasdaq: SYUT), (?Synutra? or the ?Company?), which owns subsidiaries in China that produce, distribute and sell nutritional products for inf
February 9, 2017	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): February 9, 2017 SYNUTRA INTERNATIONAL, INC.
February 9, 2017	10-Q	Synutra International FORM 10-Q (Quarterly Report) 10-Q 1 t170033310q.htm FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2016 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission file
January 23, 2017	PRER14A	Synutra International PRER14A t1603053-prer14a - block - 13.7543753s TABLE OF CONTENTS ? ? UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (RULE 14a-101) SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant?? Filed by a Party other than the Registrant? ? Check the appropriate box: ? Preliminary Proxy Statement. ? ?
January 23, 2017	SC 13E3/A	SYUT / Synutra International, Inc. / Synutra International, Inc. - AMENDEMENT NO. 1 TO SCHEDULE 13E-3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13E-3 (Amendment No. 1) (Rule 13e-100) TRANSACTION STATEMENT UNDER SECTION 13(e) OF THE SECURITIES EXCHANGE ACT OF 1934 AND RULE 13e-3 THEREUNDER RULE 13e-3 Transaction Statement Under Section 13(e) of the Securities Exchange Act of 1934 Synutra International, Inc. (Name of the Issuer) Synutra International, Inc. Beam
January 23, 2017	CORRESP	Synutra International ESP Writer?s Direct Dial: +86 10 5920 1090 E-Mail: [email protected] January 23, 2017 via edgar Ms. Tiffany Piland Posil, Special Counsel Office of Mergers and Acquisitions Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549 Re: Synutra International, Inc. Schedule 13E-3 Filed by Synutra International, Inc. et al. Filed December 9, 2016 File No. 005-80828 Preliminary Merger Prox
January 20, 2017	DEFA14A	Synutra International DEFINITIVE ADDITIONAL MATERIALS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? Definitive Proxy State
January 20, 2017	DEF 14A	Synutra International DEFINITIVE PROXY STATEMENT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant x Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) x Definitive Proxy State
December 9, 2016	PREM14A	Synutra International PRELIMINARY PROXY STATEMENT t1602970-pre14a - none - 13.5123511s TABLE OF CONTENTS ? ? UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (RULE 14a-101) SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant?? Filed by a Party other than the Registrant? ? Check the appropriate box: ? Preliminary Proxy Statement. ? ? C
December 9, 2016	EX-99.(C)(2)	EX-99.(C)(2) Exhibit (c)(2) Synutra International Inc. D ISCUSSION MATER IALS FOR THE SPEC IAL COMMITTEE JUNE 3 , 2 0 1 6 \| CONFIDENT IAL \| D R AF T -PREL IMINARY-SUBJECT TO FURTHER R EVIEW Note: This English language version is a translation of a Chinese language version that was presented to the Special Committee. Confidential – Preliminary Draft – Subject to Table of Contents Further Review 2 Page 1. Situat
December 9, 2016	EX-99.(C)(4)	EX-99.(C)(4) EX-99.(C)(4) 4 t1602958ex99-c4.htm EXHIBIT (C)(4) Exhibit (c)(4) Project Sakura DISCUSSION MATERIALS Note: This English language version is a translation of a Chinese language version that was presented to the Special Committee. NOVEMBER 1 1 , 2 0 1 6 \| CONFIDENT IAL Financial Projections – Changes Summary Confidential – Preliminary Draft – Subject to Further Review (dollars in millions) Cur r e n
December 9, 2016	EX-99.(C)(5)	Synutra International Inc. DISCUSSION MATERIALS FOR THE SPECIAL COMMITTEE NOVEMBER 17, 2016 \| CONFIDENTIAL Note: This English language version is a translation of a Chinese language version that was presented to the Special Committee. Exhibit (c)(5) Synutra International Inc. DISCUSSION MATERIALS FOR THE SPECIAL COMMITTEE NOVEMBER 17, 2016 \| CONFIDENTIAL Note: This English language version is a translation of a Chinese language version that was presented to the Special Committee. Table of Contents 2 Page 1. Summary of Changes Since September 8, 2016 3 2. Situation Overview 7 3. Selected Public Market Observations 10 4. Transact
December 9, 2016	EX-99.(C)(3)	EX-99.(C)(3) EX-99.(C)(3) 3 t1602958ex99-c3.htm EXHIBIT (C)(3) Exhibit (c)(3) Synutra International Inc. D ISCUSSION MATER IALS FOR THE SPEC IAL COMMITTEE SEPT EMBER 8 , 2 0 1 6 \| CONFIDENT IAL \| D R AF T -PREL IMINARY-SUBJECT TO FURTHER R EVIEW Note: This English language version is a translation of a Chinese language version that was presented to the Special Committee. Confidential – Preliminary Draft – Subj
December 9, 2016	SC 13E3	SYUT / Synutra International, Inc. / Synutra International, Inc. - SCHEDULE 13E-3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13E-3 (Rule 13e-100) TRANSACTION STATEMENT UNDER SECTION 13(e) OF THE SECURITIES EXCHANGE ACT OF 1934 AND RULE 13e-3 THEREUNDER RULE 13e-3 Transaction Statement Under Section 13(e) of the Securities Exchange Act of 1934 Synutra International, Inc. (Name of the Issuer) Synutra International, Inc. Beams Power Investment
November 18, 2016	SC 13D/A	SYUT / Synutra International, Inc. / Zhang Liang - FORM SC 13D/A Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A UNDER SECURITIES EXCHANGE ACT OF 1934 (Amendment No. 6)* SYNUTRA INTERNATIONAL, INC. (Name of Issuer) Common Stock, Par Value US$0.0001 Per Share (Title of Class of Securities) 87164C 10 2 (CUSIP Number) Liang Zhang 103 Dong Lu Yuan Tongzhou District, Beijing 101101 People’s Republic of China +86 10 5801 6800 (N
November 18, 2016	EX-99.5	SHANGHAI PUDONG DEVELOPMENT BANK CO., LTD. EX-99.5 2 dp70372ex9905.htm EXHIBIT 99.5 Exhibit 99.5 SHANGHAI PUDONG DEVELOPMENT BANK CO., LTD. Date: 11/17/ 2016 STRICTLY PRIVATE AND CONFIDENTIAL Beams Power Investment Limited (the "Borrower" or "you") Dongluyuan 103, Tongzhou District, Beijing, PRC Attention: Ms. MENG Xiuqing Project Beams Commitment Letter Dear Sirs, You have advised us that Beams Power Merger Sub Limited (the "Mergerco"), a
November 17, 2016	8-K	Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Other Events 8-K 1 t16028348k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): November 17, 2016 SYNUTRA INTERNATIONAL, INC. (Exact Name of Registrant as Specified in Charter) Delaware 001-33397 13-4306188 (State or Other Jurisdiction
November 17, 2016	EX-2.1	AGREEMENT AND PLAN OF MERGER by and among BEAMS POWER INVESTMENT LIMITED BEAMS POWER MERGER SUB LIMITED SYNUTRA INTERNATIONAL, INC. Dated as of November 17, 2016 TABLE OF CONTENTS Exhibit 2.1 EXECUTION VERSION AGREEMENT AND PLAN OF MERGER by and among BEAMS POWER INVESTMENT LIMITED BEAMS POWER MERGER SUB LIMITED and SYNUTRA INTERNATIONAL, INC. Dated as of November 17, 2016 TABLE OF CONTENTS Page Article I Defined Terms Section 1.01 Defined Terms 2 Section 1.02 Interpretation; Headings 9 Article II THE MERGER Section 2.01 The Merger 10 Section 2.02 Closing; Closing Date 10 S
November 17, 2016	EX-99.1	Synutra Enters into Definitive Merger Agreement for “Going Private” Transaction Exhibit 99.1 FOR IMMEDIATE RELEASE: Synutra Enters into Definitive Merger Agreement for ?Going Private? Transaction Qingdao, China and Rockville, Md. ? November 17, 2016 ? Synutra International, Inc. (Nasdaq: SYUT), (?Synutra? or the ?Company?), which owns subsidiaries in China that produce, distribute and sell nutritional products for infants, children and adults, today announced it has entered i
November 17, 2016	EX-10.1	LIMITED GUARANTEE Exhibit 10.1 EXECUTION VERSION LIMITED GUARANTEE LIMITED GUARANTEE, dated as of November 17, 2016 (this ?Limited Guarantee?), by Mr. Liang Zhang and Ms. Xiuqing Meng (the ?Guarantors? and each, a ?Guarantor?) in favor of Synutra International, Inc., a Delaware corporation (the ?Guaranteed Party?). Capitalized terms used but not defined in this Limited Guarantee shall have the meanings assigned to
November 17, 2016	EX-99.1	Synutra Enters into Definitive Merger Agreement for “Going Private” Transaction Exhibit 99.1 FOR IMMEDIATE RELEASE: Synutra Enters into Definitive Merger Agreement for ?Going Private? Transaction Qingdao, China and Rockville, Md. ? November 17, 2016 ? Synutra International, Inc. (Nasdaq: SYUT), (?Synutra? or the ?Company?), which owns subsidiaries in China that produce, distribute and sell nutritional products for infants, children and adults, today announced it has entered i
November 17, 2016	EX-10.1	LIMITED GUARANTEE Exhibit 10.1 EXECUTION VERSION LIMITED GUARANTEE LIMITED GUARANTEE, dated as of November 17, 2016 (this “Limited Guarantee”), by Mr. Liang Zhang and Ms. Xiuqing Meng (the “Guarantors” and each, a “Guarantor”) in favor of Synutra International, Inc., a Delaware corporation (the “Guaranteed Party”). Capitalized terms used but not defined in this Limited Guarantee shall have the meanings assigned to
November 17, 2016	EX-2.1	AGREEMENT AND PLAN OF MERGER by and among BEAMS POWER INVESTMENT LIMITED BEAMS POWER MERGER SUB LIMITED SYNUTRA INTERNATIONAL, INC. Dated as of November 17, 2016 TABLE OF CONTENTS Exhibit 2.1 EXECUTION VERSION AGREEMENT AND PLAN OF MERGER by and among BEAMS POWER INVESTMENT LIMITED BEAMS POWER MERGER SUB LIMITED and SYNUTRA INTERNATIONAL, INC. Dated as of November 17, 2016 TABLE OF CONTENTS Page Article I Defined Terms Section 1.01 Defined Terms 2 Section 1.02 Interpretation; Headings 9 Article II THE MERGER Section 2.01 The Merger 10 Section 2.02 Closing; Closing Date 10 S
November 17, 2016	DEFA14A	Synutra International FORM 8-K DEFA14A 1 t16028348k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): November 17, 2016 SYNUTRA INTERNATIONAL, INC. (Exact Name of Registrant as Specified in Charter) Delaware 001-33397 13-4306188 (State or Other Jurisdic
November 9, 2016	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): November 9, 2016 SYNUTRA INTERNATIONAL, INC.
November 9, 2016	EX-99.1	Synutra Reports Second Quarter Fiscal 2017 Financial Results ~2Q17 Net Sales of $82.7 million ~2Q17 Nutritional Food sales of $76.4 million EX-99.1 2 t1602713ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 FOR IMMEDIATE RELEASE: Synutra Reports Second Quarter Fiscal 2017 Financial Results ~2Q17 Net Sales of $82.7 million ~2Q17 Nutritional Food sales of $76.4 million Qingdao, China and Rockville, Md. – November 9, 2016 – Synutra International, Inc. (Nasdaq: SYUT), (“Synutra” or the “Company”), which owns subsidiaries in China that produce, distri
November 9, 2016	10-Q	Synutra International FORM 10-Q (Quarterly Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2016 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission file number 001-33397 SYNUTRA INTERNA
November 3, 2016	SC 13D/A	SYUT / Synutra International, Inc. / Warburg Pincus Private Equity IX, L.P. - SC 13D/A Activist Investment SC 13D/A 1 v452142sc13da.htm SC 13D/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A Under the Securities Exchange Act of 1934 (Amendment No. 11)* SYNUTRA INTERNATIONAL, INC. (Name of Issuer) Common Stock, Par Value $0.0001 Per Share (Title of Class of Securities) 87164C 10 2 (CUSIP Number) Robert B. Knauss, Esq. Managing Director and General Counsel Warburg
September 30, 2016	8-K	Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report: September 28, 2016 SYNUTRA INTERNATIONAL, INC.
September 30, 2016	EX-99.1	Synutra International Holds Ceremony to Commemorate Opening of New Operating Facility in Carhaix, France EX-99.1 2 t1602335ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 Synutra International Holds Ceremony to Commemorate Opening of New Operating Facility in Carhaix, France QINGDAO, China and ROCKVILLE, Md., September 30, 2016 — Synutra International, Inc. (Nasdaq: SYUT), (“Synutra” or the “Company”), which owns subsidiaries in China that produce, distribute and sell nutritional products for infants, children
August 9, 2016	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition 8-K 1 t16019598k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report: August 9, 2016 SYNUTRA INTERNATIONAL, INC. (Exact Name of Registrant as Specified in Charter) Delaware 001-33397 13-4306188 (State or Other Jurisdiction of Incorporation) (Commission File N
August 9, 2016	EX-99.1	Synutra Reports First Quarter Fiscal 2017 Financial Results ~1Q17 Net Sales of $77.9 million ~1Q17 Nutritional Food sales of $74.3 million EX-99.1 2 t1601959ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 FOR IMMEDIATE RELEASE: Synutra Reports First Quarter Fiscal 2017 Financial Results ~1Q17 Net Sales of $77.9 million ~1Q17 Nutritional Food sales of $74.3 million Qingdao, China and Rockville, Md. – August 9, 2016 – Synutra International, Inc. (Nasdaq: SYUT), (“Synutra” or the “Company”), which owns subsidiaries in China that produce, distribut
August 9, 2016	EX-99.1	Synutra Reports First Quarter Fiscal 2017 Financial Results ~1Q17 Net Sales of $77.9 million ~1Q17 Nutritional Food sales of $74.3 million EX-99.1 2 t1601959ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 FOR IMMEDIATE RELEASE: Synutra Reports First Quarter Fiscal 2017 Financial Results ~1Q17 Net Sales of $77.9 million ~1Q17 Nutritional Food sales of $74.3 million Qingdao, China and Rockville, Md. – August 9, 2016 – Synutra International, Inc. (Nasdaq: SYUT), (“Synutra” or the “Company”), which owns subsidiaries in China that produce, distribut
August 9, 2016	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition 8-K 1 t16019598k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report: August 9, 2016 SYNUTRA INTERNATIONAL, INC. (Exact Name of Registrant as Specified in Charter) Delaware 001-33397 13-4306188 (State or Other Jurisdiction of Incorporation) (Commission File N
August 9, 2016	10-Q	Synutra International FORM 10-Q (Quarterly Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2016 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission file number 001-33397 SYNUTRA INTERNATIONA
June 30, 2016	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report: June 30, 2016 SYNUTRA INTERNATIONAL, INC.
June 13, 2016	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition 8-K 1 t16014968k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report: June 13, 2016 SYNUTRA INTERNATIONAL, INC. (Exact Name of Registrant as Specified in Charter) Delaware 001-33397 13-4306188 (State or Other Jurisdiction of Incorporation) (Commission File Nu
June 13, 2016	EX-99.1	Synutra Reports Fourth Quarter and Full Year Fiscal 2016 Financial Results ~4Q16 Net Sales of $86.1 million ~4Q16 Nutritional Food sales of $80.4 million Exhibit 99.1 FOR IMMEDIATE RELEASE: Synutra Reports Fourth Quarter and Full Year Fiscal 2016 Financial Results ~4Q16 Net Sales of $86.1 million ~4Q16 Nutritional Food sales of $80.4 million Qingdao, China and Rockville, Md. ? June 13, 2016 ? Synutra International, Inc. (Nasdaq: SYUT), (?Synutra? or the ?Company?), which owns subsidiaries in China that produce, distribute and sell nutritional produ
June 13, 2016	10-K	Synutra International FORM 10-K (Annual Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended March 31, 2016 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-33397 SYNUTRA INTERNATI
June 13, 2016	EX-21.1	Subsidiaries of Synutra International, Inc. EXHIBIT 21.1 Subsidiaries of Synutra International, Inc. Subsidiary Jurisdiction Synutra, Inc. Illinois Shengyuan Nutritional Food Co., Ltd. China Inner Mongolia Huiliduo Food Co., Ltd. China Meitek Technology (Qingdao) Co., Ltd. China Inner Mongolia Mengyuan Food Co., Ltd. China Heilongjiang Longshan Dairy Co., Ltd. China Unisono B.V. Netherlands Synutra International Company Limited BVI Synutra
March 10, 2016	EX-99.3	NOTE PURCHASE AGREEMENT FNOF SHARING ECONOMY LIMITED BEAMS POWER INVESTMENT LIMITED MENG XIUQING ZHANG LIANG Dated March 2, 2016 TABLE OF CONTENTS NOTE PURCHASE AGREEMENT AMONG FNOF SHARING ECONOMY LIMITED BEAMS POWER INVESTMENT LIMITED MENG XIUQING AND ZHANG LIANG Dated March 2, 2016 TABLE OF CONTENTS Page SECTION 1 INTERPRETATION 1 1.
March 10, 2016	SC 13D/A	SYUT / Synutra International, Inc. / Zhang Liang - FORM SC 13D/A Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A UNDER SECURITIES EXCHANGE ACT OF 1934 (Amendment No. 5)* SYNUTRA INTERNATIONAL, INC. (Name of Issuer) Common Stock, Par Value US$0.0001 Per Share (Title of Class of Securities) 87164C 10 2 (CUSIP Number) Liang Zhang 103 Dong Lu Yuan Tongzhou District, Beijing 101101 People’s Republic of China +86 10 5801 6800 (N
March 1, 2016	8-K	Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of earliest event reported: February 26, 2016 Date of report: March 1, 2016 SYNUTRA INTERNATIONAL, INC.
February 5, 2016	8-K	Financial Statements and Exhibits, Other Events 8-K 1 dp632778k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report: February 5, 2016 SYNUTRA INTERNATIONAL, INC. (Exact Name of Registrant as Specified in Charter) Delaware 001-33397 13-4306188 (State or Other Jurisdiction of Incorporation) (Commission File
February 5, 2016	EX-99.1	Synutra Special Committee Engages Independent Financial Advisor and Legal Counsel in connection with “Going Private” Proposal Exhibit 99.1 Synutra Special Committee Engages Independent Financial Advisor and Legal Counsel in connection with ?Going Private? Proposal QINGDAO, China and ROCKVILLE, Md., February 5, 2016 ? Synutra International, Inc. (Nasdaq: SYUT) (?Synutra? or the ?Company?), which owns subsidiaries in China that produce, distribute and sell nutritional products for infants, children and adults, today announ
February 5, 2016	EX-99.1	Synutra Reports Third Quarter Fiscal 2016 Financial Results ~Net Sales of $109 million ~Nutritional Food sales of $96 million Exhibit 99.1 FOR IMMEDIATE RELEASE: Synutra Reports Third Quarter Fiscal 2016 Financial Results ~Net Sales of $109 million ~Nutritional Food sales of $96 million Qingdao, China and Rockville, Md. ? February 5, 2016 ? Synutra International, Inc. (Nasdaq: SYUT), (?Synutra? or the ?Company?), which owns subsidiaries in China that produce, distribute and sell nutritional products for infants, children
February 5, 2016	10-Q	SYUT / Synutra International, Inc. 10-Q - Quarterly Report - FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2015 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission file number 001-33397 SYNUTRA INTERNAT
February 5, 2016	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): February 5, 2016 SYNUTRA INTERNATIONAL, INC.
February 2, 2016	EX-99.1	Synutra Announces Receipt of Revised Non-Binding “Going Private” Proposal Exhibit 99.1 Synutra Announces Receipt of Revised Non-Binding ?Going Private? Proposal QINGDAO, China and ROCKVILLE, Md., February 2, 2016 ? Synutra International, Inc. (Nasdaq: SYUT) (?Synutra? or the ?Company?), which owns subsidiaries in China that produce, distribute and sell nutritional products for infants, children and adults, today announced that the special committee of its board of direc
February 2, 2016	8-K	Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report: February 2, 2016 SYNUTRA INTERNATIONAL, INC. (Exact Name of Registrant as Specified in its Charter) Delaware (State or other jurisdiction of incorporation) 001-33397 (Commission File Number) 13-4306188 (I.R.S. Employe
February 1, 2016	SC 13D/A	SYUT / Synutra International, Inc. / Zhang Liang - FORM SC 13D/A Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A UNDER SECURITIES EXCHANGE ACT OF 1934 (Amendment No. 4)* SYNUTRA INTERNATIONAL, INC. (Name of Issuer) Common Stock, Par Value US$0.0001 Per Share (Title of Class of Securities) 87164C 10 2 (CUSIP Number) Liang Zhang 103 Dong Lu Yuan Tongzhou District, Beijing 101101 People’s Republic of China +86 10 5801 6800 (N
February 1, 2016	EX-99.2	January 30, 2016 Exhibit 99.2 January 30, 2016 The Special Committee of the Board of Directors Synutra International, Inc. 2275 Research Blvd., Suite 500 Rockville, Maryland 20850 United States Dear Members of the Special Committee, Reference is made to our letter to the board of directors (the “Board”) of Synutra International, Inc. (the “Company”), dated January 14, 2016 (the “January 14 Letter”), in connection
January 29, 2016	DEFR14A	Synutra International FORM DEFR14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Amendment No. 1) PROXY STATEMENT PURSUANT TO SECTION 14(A) OF THE SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, For Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? Defi
January 22, 2016	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report: January 22, 2016 SYNUTRA INTERNATIONAL, INC. (Exact Name of Registrant as Specified in its Charter) Delaware (State or other jurisdiction of incorporation) 001-33397 (Commission File Number) 13-4306188 (I.R.S. Employe
January 22, 2016	EX-99.1	Synutra Announces Appointment of New Director and Formation of Special Committee EX-99.1 2 dp62769ex9901.htm EXHIBIT 99.1 Exhibit 99.1 Synutra Announces Appointment of New Director and Formation of Special Committee QINGDAO, China and ROCKVILLE, Md., January 22, 2016 — Synutra International, Inc. (Nasdaq: SYUT), (“Synutra” or the “Company”), which owns subsidiaries in China that produce, distribute and sell nutritional products for infants, children and adults, today announced
January 15, 2016	EX-99.1	* * * * * * Exhibit 99.1 CONFIDENTIAL January 14, 2016 The Board of Directors Synutra International, Inc. 2275 Research Blvd., Suite 500 Rockville, Maryland 20850 United States Dear Members of the Board of Directors, Mr. Liang Zhang (“Mr. Zhang”), chairman of the board of directors of Synutra International, Inc. (the “Company”), and Beams Power Investment Limited (together with Mr. Zhang, the “Buyer Parties”)
January 15, 2016	8-K	Synutra International FORM 8-K (Current Report/Significant Event) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report: January 15, 2016 SYNUTRA INTERNATIONAL, INC.
January 15, 2016	DEF 14A	Synutra International FORM DEF 14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(A) OF THE SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, For Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? Definitive Proxy State
January 15, 2016	SC 13D/A	SYUT / Synutra International, Inc. / Zhang Liang - FORM SC 13D/A Activist Investment SC 13D/A 1 dp62619sc13da.htm FORM SC 13D/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A UNDER SECURITIES EXCHANGE ACT OF 1934 (Amendment No. 3)* SYNUTRA INTERNATIONAL, INC. (Name of Issuer) Common Stock, Par Value US$0.0001 Per Share (Title of Class of Securities) 87164C 10 2 (CUSIP Number) Liang Zhang 103 Dong Lu Yuan Tongzhou District, Beijing 101101 Peo
January 15, 2016	EX-99.1	* * * * * * Exhibit 99.1 Synutra Announces Receipt of Preliminary Non-Binding ?Going Private? Proposal QINGDAO, China and ROCKVILLE, Md., January 15, 2016 ? Synutra International, Inc. (Nasdaq: SYUT), ("Synutra" or the "Company"), which owns subsidiaries in China that produce, distribute and sell nutritional products for infants, children and adults, today announced that its board of directors (the ?Board?) h
December 23, 2015	EX-99.8	TERMINATION AGREEMENT Exhibit 99.8 TERMINATION AGREEMENT This TERMINATION AGREEMENT (this “Agreement”) is entered into on December 22, 2015, by and between Warburg Pincus Private Equity IX, L.P. (“WP”) and Sparkle Wealthy Limited (“Sparkle Wealthy”). WP and Sparkle Wealthy are collectively referred to as “Parties”, and individually as a “Party”. RECITALS WHEREAS the Parties hereto entered into that certain share purcha
December 23, 2015	SC 13D/A	SYUT / Synutra International, Inc. / Warburg Pincus Private Equity IX, L.P. - SC 13D/A Activist Investment SC 13D/A 1 v427671sc13da.htm SC 13D/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A Under the Securities Exchange Act of 1934 (Amendment No. 10)* SYNUTRA INTERNATIONAL, INC. (Name of Issuer) Common Stock, Par Value $0.0001 Per Share (Title of Class of Securities) 87164C 10 2 (CUSIP Number) Robert B. Knauss, Esq. Managing Director and General Counsel Warburg
November 9, 2015	8-K	Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report: November 9, 2015 SYNUTRA INTERNATIONAL, INC.
November 9, 2015	EX-99.1	Synutra Reports Second Quarter Fiscal 2016 Financial Results Exhibit 99.1 Synutra Reports Second Quarter Fiscal 2016 Financial Results ~ Net Sales of $87 million ~ Nutritional Food sales of $78 million QINGDAO, China and ROCKVILLE, Md., Nov. 9, 2015 /PRNewswire/ - Synutra International, Inc. (Nasdaq: SYUT), ("Synutra" or the "Company"), which owns subsidiaries in China that produce, distribute and sell nutritional products for infants, children and adults,
November 9, 2015	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q 10-Q 1 dp6105310q.htm FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2015 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission file
September 28, 2015	SC 13D/A	SYUT / Synutra International, Inc. / Warburg Pincus Private Equity IX, L.P. Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A Under the Securities Exchange Act of 1934 (Amendment No. 9)* SYNUTRA INTERNATIONAL, INC. (Name of Issuer) Common Stock, Par Value $0.0001 Per Share (Title of Class of Securities) 87164C 10 2 (CUSIP Number) Robert B. Knauss, Esq. Managing Director and General Counsel Warburg Pincus LLC 450 Lexington Avenue New Yo
September 28, 2015	EX-99.7	AMENDMENT TO SHARE PURCHASE AGREEMENT EXHIBIT 99.7 AMENDMENT TO SHARE PURCHASE AGREEMENT This AMENDMENT TO SHARE PURCHASE AGREEMENT, dated as of September 25, 2015 (this “Amendment”), is made and entered into by and between Warburg Pincus Private Equity IX, L.P. (the "Seller") and Sparkle Wealthy Limited (the "Purchaser"). WITNESSETH: WHEREAS, the parties hereto are parties to a Share Purchase Agreement dated September 14, 2015 (the “
September 14, 2015	EX-99.6	SHARE PURCHASE AGREEMENT EXHIBIT 99.6 SHARE PURCHASE AGREEMENT THIS SHARE PURCHASE AGREEMENT, dated as of September 14, 2015 (this "Agreement"), is made and entered into by and among Warburg Pincus Private Equity IX, L.P. (the "Seller"), and Sparkle Wealthy Limited (the "Purchaser"). W I T N E S S E T H: WHEREAS, the Seller is the record and beneficial owner of 4,000,000 shares of common stock, par value $0.0001 per share
September 14, 2015	EX-99.5	JOINT FILING AGREEMENT EX-99.5 2 jointfilingagreement.htm JOINT FILING AGREEMENT EXHIBIT 99.5 JOINT FILING AGREEMENT THIS JOINT FILING AGREEMENT is entered into as of September 14, 2015, by and among the parties signatories hereto. The undersigned hereby agree that the Amendment No. 8 to the Statement on Schedule 13D/A with respect to the shares of Common Stock, par value $0.0001 per share, of Synutra International, Inc
September 14, 2015	SC 13D/A	SYUT / Synutra International, Inc. / Warburg Pincus Private Equity IX, L.P. Activist Investment SC 13D/A 1 synutrainternational.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A Under the Securities Exchange Act of 1934 (Amendment No. 8)* SYNUTRA INTERNATIONAL, INC. (Name of Issuer) Common Stock, Par Value $0.0001 Per Share (Title of Class of Securities) 87164C 10 2 (CUSIP Number) Robert B. Knauss, Esq. Managing Director and General Counsel Warburg Pi
September 10, 2015	EX-99.1	Synutra Announces Share Repurchase Program Exhibit 99.1 Synutra Announces Share Repurchase Program Qingdao, China and Rockville, Md. ? September 10, 2015 ? Synutra International, Inc. (Nasdaq: SYUT), (?Synutra? or the ?Company?), which owns subsidiaries in China that produce, distribute and sell nutritional products for infants, children and adults, today announced that its board of directors has approved a share repurchase program under w
September 10, 2015	8-K	Regulation FD Disclosure UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 10, 2015 SYNUTRA INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 001-33397 (Commission Fil
September 1, 2015	EX-99.1	Synutra Announces Director Resignation Exhibit 99.1 FOR IMMEDIATE RELEASE: Synutra Announces Director Resignation Qingdao, China and Rockville, Md. ? September 1, 2015 ? Synutra International, Inc. (Nasdaq: SYUT), (?Synutra? or the ?Company?), which owns subsidiaries in China that produce, distribute and sell nutritional products for infants, children and adults, today announced that effective on September 1, 2015, Joseph Chow will res
September 1, 2015	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 8-K 1 dp593298k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report: September 1, 2015 Date of earliest event reported: August 31, 2015 SYNUTRA INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction
August 10, 2015	EX-99.1	Synutra Reports First Quarter Fiscal 2016 Financial Results --Reiterates Fiscal 2016 Financial Outlook-- FOR IMMEDIATE RELEASE: Synutra Reports First Quarter Fiscal 2016 Financial Results -Reiterates Fiscal 2016 Financial Outlook- Qingdao, China and Rockville, Md.
August 10, 2015	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2015 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission file number 001-33397 SYNUTRA INTERNATIONA
August 10, 2015	8-K	Synutra International FORM 8-K (Current Report/Significant Event) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): August 10, 2015 SYNUTRA INTERNATIONAL, INC.
June 12, 2015	EX-21.1	Subsidiary EXHIBIT 21.1 Subsidiaries of Synutra International, Inc. Subsidiary Jurisdiction Synutra, Inc. Illinois Shengyuan Nutritional Food Co., Ltd. China Inner Mongolia Huiliduo Food Co., Ltd. China Meitek Technology (Qingdao) Co., Ltd. China Inner Mongolia Mengyuan Food Co., Ltd. China Heilongjiang Longshan Dairy Co., Ltd. China Unisono B.V. Netherlands Synutra International Company Limited BVI Synutra
June 12, 2015	EX-99.1	Synutra Reports Fourth Quarter and Full Year Fiscal 2015 Financial Results Synutra Reports Fourth Quarter and Full Year Fiscal 2015 Financial Results ~4Q15 Sales Increase 11.
June 12, 2015	10-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended March 31, 2015 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission file number 001-33397 SYNUTRA INTERNATIONAL, INC.
June 12, 2015	8-K	Synutra International FORM 8-K (Current Report/Significant Event) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report: June 12, 2015 SYNUTRA INTERNATIONAL, INC.
March 17, 2015	8-K	Synutra International FORM 8-K (Current Report/Significant Event) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report: March 17, 2015 Date of earliest event reported: March 12, 2015 SYNUTRA INTERNATIONAL, INC.
February 9, 2015	EX-99.1	Synutra Reports Third Quarter and First Nine Months of Fiscal 2015 Financial Results ~3Q15 Sales Increase 14.2% Over Prior Year Period~ ~Formula Sales Increase 23.7%~ ~3Q15 Net Income Increases 84.1% Over Prior Year Period~ FOR IMMEDIATE RELEASE: Synutra Reports Third Quarter and First Nine Months of Fiscal 2015 Financial Results ~3Q15 Sales Increase 14.
February 9, 2015	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): February 9, 2015 SYNUTRA INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 001-33397 (Commission File
February 9, 2015	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2014 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission file number 001-33397 SYNUTRA INTERNAT
January 28, 2015	DEF 14A	SYUT / Synutra International, Inc. DEF 14A - - FORM DEF 14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(A) OF THE SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant ý Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, For Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ý Definitive Proxy State
November 14, 2014	EX-99.1	Synutra Announces Director Resignation Exhibit 99.1 FOR IMMEDIATE RELEASE: Synutra Announces Director Resignation Qingdao, China and Rockville, Md. – November14, 2014 – Synutra International, Inc. (Nasdaq: SYUT), (“Synutra” or the “Company”), which owns subsidiaries in China that produce, distributeand sell nutritional products for infants, children and adults, today announcedthat effective November 11, 2014, David Li, a Managing Direc
November 14, 2014	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report: November 14, 2014 Date of earliest event reported: November 11, 2014 SYNUTRA INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 001-33397
November 10, 2014	EX-99.1	Synutra Reports Second Quarter Fiscal 2015 Financial Results ~2Q15 Sales Increase 15.7% Over Prior Year Period~ ~Formula Sales Increase 29.5%~ ~2Q15 Net Income Attributable to Common Stockholders Increase 68.6% Over Prior Year Period~ ~Raises FY15 Ne FOR IMMEDIATE RELEASE: Synutra Reports Second Quarter Fiscal 2015 Financial Results ~2Q15 Sales Increase 15.
November 10, 2014	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): November 10, 2014 SYNUTRA INTERNATIONAL, INC.
November 10, 2014	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2014 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission file number 001-33397 SYNUTRA INTERNA
August 8, 2014	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): August 8, 2014 SYNUTRA INTERNATIONAL, INC.
August 8, 2014	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2014 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission file number 001-33397 SYNUTRA INTERNATIONA
August 8, 2014	EX-99.1	Synutra Reports First Quarter Fiscal 2015 Financial Results ~ 1Q15 Sales Increase 4.6%~ ~Formula Sales Increase 20.8%~ ~ Reiterates FY15 Guidance Forecast ~ Exhibit 99.1 FOR IMMEDIATE RELEASE: Synutra Reports First Quarter Fiscal 2015 Financial Results ~ 1Q15 Sales Increase 4.6%~ ~Formula Sales Increase 20.8%~ ~ Reiterates FY15 Guidance Forecast ~ Qingdao, China and Rockville, Md. – August 8, 2014 – Synutra International, Inc. (Nasdaq: SYUT), (“Synutra” or the “Company”), which owns subsidiaries in China that produce, distribute and sell nutritional p
June 16, 2014	EX-99.1	Synutra Reports Fourth Quarter and Full Year of Fiscal 2014 Financial Results ~ 4Q14 Sales Increase 36% YoY while 4Q14 Net Income Increases 195% YoY ~ ~ Reiterates FY15 Sales and Earnings Guidance Forecast ~ Exhibit 99.1 FOR IMMEDIATE RELEASE: Synutra Reports Fourth Quarter and Full Year of Fiscal 2014 Financial Results ~ 4Q14 Sales Increase 36% YoY while 4Q14 Net Income Increases 195% YoY ~ ~ Reiterates FY15 Sales and Earnings Guidance Forecast ~ Qingdao, China and Rockville, Md. – June 16, 2014 – Synutra International, Inc. (NASDAQ: SYUT), (“Synutra” or the “Company”), which owns subsidiaries in Chi
June 16, 2014	10-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended March 31, 2014 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission file number 001-33397 SYNUTRA INTERNATIONAL, INC.
June 16, 2014	EX-21.1	Subsidiary EXHIBIT 21.1 Subsidiaries of Synutra International, Inc. Subsidiary Jurisdiction Synutra, Inc. Illinois Shengyuan Nutritional Food Co., Ltd. China Zhangjiakou Chahaer Dairy Co., Ltd. China Inner Mongolia Huiliduo Food Co., Ltd. China Meitek Technology (Qingdao) Co., Ltd. China Inner Mongolia Mengyuan Food Co., Ltd. China Beijing Shengyuan Huiliduo Food Technology Co., Ltd. China Heilongjiang Longs
June 16, 2014	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): June 16, 2014 SYNUTRA INTERNATIONAL, INC.
May 12, 2014	EX-99.1	Synutra Announces Preliminary Fourth Quarter and Full Year 2014 Financial Results --Provides Preliminary FY15 Growth Forecast— FOR IMMEDIATE RELEASE: Synutra Announces Preliminary Fourth Quarter and Full Year 2014 Financial Results -Provides Preliminary FY15 Growth Forecast— Qingdao, China and Rockville, Md.
May 12, 2014	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): May 12, 2014 SYNUTRA INTERNATIONAL, INC.
March 6, 2014	8-K	Submission of Matters to a Vote of Security Holders - FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): March 5, 2014 SYNUTRA INTERNATIONAL, INC.
March 5, 2014	8-K	Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): March 3, 2014 SYNUTRA INTERNATIONAL, INC.
March 5, 2014	EX-4.1	REGISTRATION RIGHTS AGREEMENT Exhibit 4.1 REGISTRATION RIGHTS AGREEMENT BY AND AMONG SYNUTRA INTERNATIONAL, INC. (SYUT), the Company; BEAMS POWER INVESTMENT LIMITED, the Pledgor; and DEUTSCHE BANK AG, HONG KONG BRANCH the Facility Agent dated as of March 3, 2014 CONTENTS Section Page 1. Certain Definitions 1 2. Registration 3 3. Suspension 8 4. Company Obligations 9 5. Obligations of the Facility Agent 12 6. Indemnification 13
March 3, 2014	SC 13D/A	SYUT / Synutra International, Inc. / Warburg Pincus Private Equity IX, L.P. - SC 13D/A Activist Investment SC 13D/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A Under the Securities Exchange Act of 1934 (Amendment No. 7)* SYNUTRA INTERNATIONAL, INC. (Name of Issuer) Common Stock, Par Value $0.0001 Per Share (Title of Class of Securities) 87164C 10 2 (CUSIP Number) Robert B. Knauss, Esq. Managing Director and General Counsel Warburg Pincus LLC 450 Lexington Aven
February 10, 2014	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2013 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission file number 001-33397 SYNUTRA INTERNAT
February 10, 2014	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): February 10, 2014 SYNUTRA INTERNATIONAL, INC.
February 10, 2014	EX-99.1	Synutra Reports Third Quarter and First Nine Months of Fiscal 2014 Financial Results ~ Exceeds 3Q14 Sales and Earnings Forecast ~ ~ Provides 4Q14 Sales and Earnings Guidance Forecast ~ EXHIBIT 99.1 FOR IMMEDIATE RELEASE: Synutra Reports Third Quarter and First Nine Months of Fiscal 2014 Financial Results ~ Exceeds 3Q14 Sales and Earnings Forecast ~ ~ Provides 4Q14 Sales and Earnings Guidance Forecast ~ Qingdao, China and Rockville, Md. – February 10, 2014 – Synutra International, Inc. (NASDAQ: SYUT), (“Synutra” or the “Company”), which owns subsidiaries in China that produce, di
January 22, 2014	DEF 14A	- DEF 14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(A) OF THE SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant ý Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, For Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ý Definitive Proxy State
November 8, 2013	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2013 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission file number 001-33397 SYNUTRA INTERNA
November 8, 2013	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition 8-K 1 dp418208k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): November 8, 2013 SYNUTRA INTERNATIONAL, INC. (Exact Name of Registrant as Specified in Charter) Delaware 001-33397 13-4306188 (State or Other Jurisdiction o
November 8, 2013	EX-99.1	Synutra Reports Second Quarter Fiscal 2014 Financial Results ~ Exceeds 2Q14 Sales and Earnings Forecast ~ ~ Provides 3Q14 Sales and Earnings Guidance Forecast ~ EXHIBIT 99.1 FOR IMMEDIATE RELEASE: Synutra Reports Second Quarter Fiscal 2014 Financial Results ~ Exceeds 2Q14 Sales and Earnings Forecast ~ ~ Provides 3Q14 Sales and Earnings Guidance Forecast ~ Qingdao, China and Rockville, Md. – November 8, 2013 – Synutra International, Inc. (NASDAQ: SYUT), (“Synutra” or the “Company”), which owns subsidiaries in China that produce, distribute and sell nutriti
August 8, 2013	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2013 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission file number 001-33397 SYNUTRA INTERNATIONA
August 8, 2013	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition - FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): August 8, 2013 SYNUTRA INTERNATIONAL, INC.
August 8, 2013	EX-99.1	Synutra Reports First Quarter Fiscal 2014 Financial Results ~ Formula Sales Recovery Demonstrates Effectiveness of Gold Mining Program ~ ~ Exceeds 1Q14 Sales Forecast ~ EXHIBIT 99.1 Synutra Reports First Quarter Fiscal 2014 Financial Results ~ Formula Sales Recovery Demonstrates Effectiveness of Gold Mining Program ~ ~ Exceeds 1Q14 Sales Forecast ~ Qingdao, China and Rockville, Md. – August 8, 2013 – Synutra International, Inc. (NASDAQ: SYUT), (“Synutra” or the “Company”), which owns subsidiaries in China that produce, distribute and sell nutritional products for
June 13, 2013	EX-99.1	Synutra Reports Fourth Quarter and Full Year Fiscal 2013 Financial Results EXHIBIT 99.1 FOR IMMEDIATE RELEASE: Synutra Reports Fourth Quarter and Full Year Fiscal 2013 Financial Results Qingdao, China and Rockville, Md. – June 13, 2013 – Synutra International, Inc. (NASDAQ: SYUT), (“Synutra” or the “Company”), which owns subsidiaries in China that produce, distribute and sell nutritional products for infants, children and adults, today announced financial results for the
June 13, 2013	10-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended March 31, 2013 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission file number 001-33397 SYNUTRA INTERNATIONAL, INC.
June 13, 2013	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition - FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): June 13, 2013 SYNUTRA INTERNATIONAL, INC.
June 13, 2013	EX-10.5	EMPLOYMENT AGREEMENT EX-10.5 2 dp38786ex1005.htm EXHIBIT 10.5 EXHIBIT 10.5 EMPLOYMENT AGREEMENT Party A (Employer) Name: Sheng Yuan Nutritional Food Co., Ltd., Beijing R&D Center Address: No. 106, Dongluyuan, Tongzhou District, Beijing Party B (Employee): Name: Ning Cai Sex: Female Passport Number: Party A Name: Sheng Yuan Nutritional Food Co., Ltd., Beijing R&D Center Legal person: Liang Zhang Address: No. 106, Dongl
June 13, 2013	EX-21.1	Subsidiary EXHIBIT 21.1 Subsidiaries of Synutra International, Inc. Subsidiary Jurisdiction Synutra, Inc. Illinois Shengyuan Nutritional Food Co., Ltd. China Zhangjiakou Chahaer Dairy Co., Ltd. China Inner Mongolia Huiliduo Food Co., Ltd. China Meitek Technology (Qingdao) Co., Ltd. China Inner Mongolia Mengyuan Food Co., Ltd. China Beijing Shengyuan Huiliduo Food Technology Co., Ltd. China Heilongjiang Longs
March 7, 2013	8-K	- FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): March 5, 2013 SYNUTRA INTERNATIONAL, INC. (Exact Name of Registrant as Specified in Charter) Delaware (State of Incorporation) 00-33397 13-4306188 (Commission File Number) (I.R.S. Emp
February 13, 2013	DEFA14A	- DEFA14A UNITED STATES UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION PROXY STATEMENT PURSUANT TO SECTION 14(A) OF THE SECURITIES EXCHANGE ACT OF 1934 (AMENDMENT NO. 1) Filed by the Registrant ý Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, For Use of the Commission Only (as permitted b
February 12, 2013	8-K	- FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): February 12, 2013 SYNUTRA INTERNATIONAL, INC. (Exact Name of Registrant as Specified in Charter) Delaware (State of Incorporation) 00-33397 13-4306188 (Commission File Number) (I.R.S.
February 8, 2013	EX-99.1	Synutra Reports Third Quarter and First Nine Months of Fiscal 2013 Financial Results EX-99.1 2 dp36109ex9901.htm EXHIBIT 99.1 Exhibit 99.1 FOR IMMEDIATE RELEASE: Synutra Reports Third Quarter and First Nine Months of Fiscal 2013 Financial Results Qingdao, China and Rockville, Md. – February 8, 2013 – Synutra International, Inc. (NASDAQ: SYUT), (“Synutra” or the “Company”), which owns subsidiaries in China that produce, market and sell nutritional products for infants, children and
February 8, 2013	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition - FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): February 8, 2013 SYNUTRA INTERNATIONAL, INC.
February 8, 2013	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2012 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission file number 001-33397 SYNUTRA INTERNAT
February 4, 2013	EX-21	BEAMS POWER INVESTMENT LIMITED SECOND RESTATED SENIOR EXCHANGEABLE NOTE EX-21 3 a13-42041ex21.htm EX-21 Exhibit 21 THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS NOTE HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, PLEDGED, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR THE SECURITIES UNDER THE SECURITIES
February 4, 2013	EX-22	AMENDMENT NO. 1 TO DRAG-ALONG AGREEMENT Exhibit 22 AMENDMENT NO. 1 TO DRAG-ALONG AGREEMENT THIS AMENDMENT NO. 1 (this “Amendment”) to the Drag-Along Agreement dated as of August 10, 2011 (the “Drag-Along Agreement”) by and between Beams Power Investment Limited, a company with limited liability registered under the BVI Business Companies Act, 2004 (as amended) of the British Virgin Islands (“Beams Power”), and Warburg Pincus Private Equ
February 4, 2013	SC 13D/A	SYUT / Synutra International, Inc. / Warburg Pincus Private Equity IX, L.P. - SC 13D/A Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A Under the Securities Exchange Act of 1934 (Amendment No. 6)* SYNUTRA INTERNATIONAL, INC. (Name of Issuer) Common Stock, Par Value $0.0001 Per Share (Title of Class of Securities) 87164C 10 2 (CUSIP Number) Scott A. Arenare, Esq. Managing Director and General Counsel Warburg Pincus LLC 450 Lexington Avenue New Yo
February 4, 2013	EX-20	RESTATED FORBEARANCE AGREEMENT EX-20 2 a13-42041ex20.htm EX-20 Exhibit 20 RESTATED FORBEARANCE AGREEMENT THIS RESTATED FORBEARANCE AGREEMENT (this “Agreement”) is made as of January 30, 2013, by and between Beams Power Investment Limited, a company with limited liability registered under the BVI Business Companies Act, 2004 (as amended) of the British Virgin Islands (“Borrower”), and Warburg Pincus Private Equity IX, L.P. (toge
February 1, 2013	DEF 14A	- DEF 14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(A) OF THE SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant ý Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, For Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ý Definitive Proxy State
December 20, 2012	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits - FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): December 18, 2012 SYNUTRA INTERNATIONAL, INC.
December 20, 2012	EX-99.1	Synutra Announces Appointment of New Chief Financial Officer EX-99.1 2 dp35006ex9901.htm EXHIBIT 99.1 Exhibit 99.1 FOR IMMEDIATE RELEASE: Synutra Announces Appointment of New Chief Financial Officer Qingdao, China and Rockville, Md. – December 20, 2012 – Synutra International, Inc. (NASDAQ: SYUT), (“Synutra” or the “Company”), which owns subsidiaries in China that produce, market and sell nutritional products for infants, children and adults, today announce
November 9, 2012	EX-10.4	FAT-ENRICHED OR NON FAT-ENRICHED DEMINERALIZED WHEY POWDER SUPPLY AGREEMENT Exhibit 10.4 CONFIDENTIAL TREATMENT HAS BEEN REQUESTED FOR THE REDACTED PORTIONS OF THIS AGREEMENT. THE REDACTIONS ARE INDICATED WITH THREE ASTERISKS ([***]). FAT-ENRICHED OR NON FAT-ENRICHED DEMINERALIZED WHEY POWDER SUPPLY AGREEMENT BETWEEN THE UNDERSIGNED: Eurosérum SAS A simplified joint stock company with a capital of €18,560,928, headquartered at Port Sur Saone 70170 – Route de Luxeuil les b
November 9, 2012	EX-10.3	WHEY SUPPLY AGREEMENT Exhibit 10.3 CONFIDENTIAL TREATMENT HAS BEEN REQUESTED FOR THE REDACTED PORTIONS OF THIS AGREEMENT. THE REDACTIONS ARE INDICATED WITH THREE ASTERISKS ([***]). WHEY SUPPLY AGREEMENT BETWEEN THE UNDERSIGNED: Eurosérum SAS A simplified joint stock company, with capital of €18,560,928, headquartered at Port Sur Saone (70170) Route de Luxeuil les bains, registered at the Commercial and Corporate Regist
November 9, 2012	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition - FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): November 9, 2012 SYNUTRA INTERNATIONAL, INC.
November 9, 2012	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2012 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission file number 001-33397 SYNUTRA INTERNA
November 9, 2012	EX-10.2	MILK SUPPLY AGREEMENT EX-10.2 3 dp32846ex1002.htm EXHIBIT 10.2 Exhibit 10.2 CONFIDENTIAL TREATMENT HAS BEEN REQUESTED FOR THE REDACTED PORTIONS OF THIS AGREEMENT. THE REDACTIONS ARE INDICATED WITH THREE ASTERISKS ([***]). MILK SUPPLY AGREEMENT BETWEEN THE UNDERSIGNED: SODIAAL UNION An agricultural cooperative company with variable capital, registered under No. 2245, headquartered at Paris (75014) 170 bis, boulevard du
November 9, 2012	EX-99.1	Synutra Reports Second Quarter and First Half Fiscal 2013 Financial Results EXHIBIT 99.1 FOR IMMEDIATE RELEASE: Synutra Reports Second Quarter and First Half Fiscal 2013 Financial Results Qingdao, China and Rockville, Md. – November 9, 2012 – Synutra International, Inc. (NASDAQ: SYUT), (“Synutra” or the “Company”), which owns subsidiaries in China that produce, market and sell nutritional products for infants, children and adults, today announced financial results for the
November 9, 2012	EX-10.1	PARTNERSHIP FRAMEWORK AGREEMENT EX-10.1 2 dp32846ex1001.htm EXHIBIT 10.1 Exhibit 10.1 PARTNERSHIP FRAMEWORK AGREEMENT BETWEEN THE UNDERSIGNED: SODIAAL UNION An agricultural cooperative company with variable capital, registered under No. 2245, headquartered at Paris (75014) 170 bis, boulevard du Montparnasse, registered at the Commercial and Corporate Registry of Paris under number D 351 572 888, Represented by Mr. François Iches
September 21, 2012	8-K	Other Events 8-K 1 dp328378k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): September 17, 2012 SYNUTRA INTERNATIONAL, INC. (Exact Name of Registrant as Specified in Charter) Delaware 001-33397 13-4306188 (State or Other Jurisdiction
August 9, 2012	EX-99.1	Synutra Reports First Quarter Fiscal 2013 Financial Results EX-99.1 2 dp32179ex9901.htm EXHIBIT 99.1 EXHIBIT 99.1 FOR IMMEDIATE RELEASE: Synutra Reports First Quarter Fiscal 2013 Financial Results Qingdao, China and Rockville, Md. – August 9, 2012 – Synutra International, Inc. (NASDAQ: SYUT), (“Synutra” or the “Company”), which owns subsidiaries in China that produce, market and sell nutritional products for infants, children and adults, today announced fi
August 9, 2012	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): August 9, 2012 SYNUTRA INTERNATIONAL, INC.
August 9, 2012	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2012 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission file number 001-33397 SYNUTRA INTERNATIONA
June 14, 2012	EX-21.1	Subsidiary EXHIBIT 21.1 Subsidiaries of Synutra International, Inc. Subsidiary Jurisdiction Synutra, Inc. Illinois Shengyuan Nutritional Food Co., Ltd. China Heilongjiang Mingshan Dairy Co., Ltd. China Zhangjiakou Chahaer Dairy Co., Ltd. China Inner Mongolia Huiliduo Food Co., Ltd. China Meitek Technology (Qingdao) Co., Ltd. China Heilongjiang Baoquanling Shengyuan Dairy Co., Ltd. China Inner Mongolia Mengyu
June 14, 2012	10-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K o ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended March 31, 2012 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission file number 000-50601 SYNUTRA INTERNATIONAL, INC.
June 14, 2012	EX-10.6	EMPLOYMENT AGREEMENT Exhibit 10.6 EMPLOYMENT AGREEMENT Party A (Employer) Name: Sheng Yuan Nutritional Food Co., Ltd., Beijing R&D Center Address: No. 106, Dongluyuan, Tongzhou District, Beijing Party B (Employee): Name: Feng Zha Sex: Male ID Number: 310104196310102813 Party A Name: Sheng Yuan Nutritional Food Co., Ltd., Beijing R&D Center Legal person: Liang Zhang Address: No. 106, Dongluyuan, Tongzhou District, Beij
June 14, 2012	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): June 14, 2012 SYNUTRA INTERNATIONAL, INC.
June 14, 2012	EX-99.1	Synutra Reports Fourth Quarter and Full Year Fiscal 2012 Financial Results --Company Emerges Profitable from Consecutive Years of Industry Crises-- Exhibit 99.1 FOR IMMEDIATE RELEASE: Synutra Reports Fourth Quarter and Full Year Fiscal 2012 Financial Results -Company Emerges Profitable from Consecutive Years of Industry Crises- Qingdao, China and Rockville, Md. – June 14, 2012 – Synutra International, Inc. (NASDAQ: SYUT), (“Synutra” or the “Company”), which owns subsidiaries in China that produce, market and sell nutritional products for infa
June 14, 2012	EX-10.5	EMPLOYMENT AGREEMENT Exhibit 10.5 EMPLOYMENT AGREEMENT Party A (Employer) Name: Sheng Yuan Nutritional Food Co., Ltd., Beijing R&D Center Address: No. 106, Dongluyuan, Tongzhou District, Beijing Party B (Employee): Name: Xisen Mu Sex: Male ID Number: 230103195711154816 Party A Name: Sheng Yuan Nutritional Food Co., Ltd., Beijing R&D Center Legal person: Liang Zhang Address: No. 106, Dongluyuan, Tongzhou District, Beij
June 14, 2012	EX-12.1	SYNUTRA INTERNATIONAL, INC. COMPUTATION OF RATIO OF EARNINGS TO FIXED CHARGES EXHIBIT 12.1 SYNUTRA INTERNATIONAL, INC. COMPUTATION OF RATIO OF EARNINGS TO FIXED CHARGES Year Ended March 31, 2012 2011 2010 2009 2008 (In thousands, except ratios) Fixed charges: Interest expense $ 14,276 $ 10,321 $ 8,603 $ 4,857 $ 6,354 Capitalized interest — — 346 1,424 848 Estimation of the interest within rental expense 326 411 500 468 163 Total fixed charges $ 14,602 $ 10,732 $ 9,449 $ 6,7
February 27, 2012	8-K	- FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): February 23, 2012 SYNUTRA INTERNATIONAL, INC. (Exact Name of Registrant as Specified in Charter) Delaware (State of Incorporation) 00-33397 13-4306188 (Commission File Number) (I.R.S.
February 9, 2012	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): February 9, 2012 SYNUTRA INTERNATIONAL, INC.
February 9, 2012	EX-99.1	Synutra Reports Third Quarter and First Nine Months of Fiscal 2012 Financial Results 3Q12 Formula Sales Rose to 3 Year Record High of $99.8 million 3Q12 Gross Margin was 41.3% 3Q12 Net Income Increases to $10.3 million EXHIBIT 99.1 FOR IMMEDIATE RELEASE: Synutra Reports Third Quarter and First Nine Months of Fiscal 2012 Financial Results 3Q12 Formula Sales Rose to 3 Year Record High of $99.8 million 3Q12 Gross Margin was 41.3% 3Q12 Net Income Increases to $10.3 million Qingdao, China and Rockville, Md. – February 9, 2012 – Synutra International, Inc. (NASDAQ: SYUT), (“Synutra” or the “Company”), which owns subsi
February 9, 2012	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2011 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission file number 001-33397 SYNUTRA INTERNAT
January 20, 2012	EX-99.1	Synutra Provides Government Testing Results Regarding Infant Formula Safety Sales and Earnings Estimates Unchanged for 3Q12 EXHIBIT 99.1 FOR IMMEDIATE RELEASE: Synutra Provides Government Testing Results Regarding Infant Formula Safety Sales and Earnings Estimates Unchanged for 3Q12 Qingdao, China and Rockville, Md. – January 20, 2012 – Synutra International, Inc. (NASDAQ: SYUT), (“Synutra” or the “Company”), which owns subsidiaries in China that produce, market and sell nutritional products for infants, children and a
January 20, 2012	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition - FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): January 20, 2012 SYNUTRA INTERNATIONAL, INC.
January 13, 2012	DEF 14A	- DEF 14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(A) OF THE SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant ý Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, For Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ý Definitive Proxy State
December 12, 2011	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): December 12, 2011 SYNUTRA INTERNATIONAL, INC.
December 12, 2011	EX-99.1	Synutra to Relocate Facilities and Corporate Campus Eyes Quarterly Net Sales Reaching Three-Year High EXHIBIT 99.1 FOR IMMEDIATE RELEASE: Synutra to Relocate Facilities and Corporate Campus Eyes Quarterly Net Sales Reaching Three-Year High Qingdao, China and Rockville, Md. – December 12, 2011 – Synutra International, Inc. (NASDAQ: SYUT), (“Synutra” or the “Company”), which owns subsidiaries in China that produce, market and sell nutritional products for infants, children and adults, today announce
November 9, 2011	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): November 9, 2011 SYNUTRA INTERNATIONAL, INC.
November 9, 2011	EX-99.1	Synutra Reports Second Quarter and First Half Fiscal 2012 Financial Results Branded Formula Sales Demonstrate Sustained Recovery 2Q12 Formula Sales were $79.1 million 2Q12 Gross Margin Rose to 42.4% 2Q12 Net Income was $8.5 million EXHIBIT 99.1 FOR IMMEDIATE RELEASE: Synutra Reports Second Quarter and First Half Fiscal 2012 Financial Results Branded Formula Sales Demonstrate Sustained Recovery 2Q12 Formula Sales were $79.1 million 2Q12 Gross Margin Rose to 42.4% 2Q12 Net Income was $8.5 million Qingdao, China and Rockville, Md. – November 9, 2011 – Synutra International, Inc. (NASDAQ: SYUT), (“Synutra” or the “Company”), whi
November 9, 2011	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2011 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission file number 001-33397 SYNUTRA INTERNA
August 29, 2011	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): August 29, 2011 SYNUTRA INTERNATIONAL, INC.
August 29, 2011	EX-99.1	Synutra Announces Appointment of Interim CFO EXHIBIT 99.1 FOR IMMEDIATE RELEASE: Synutra Announces Appointment of Interim CFO Qingdao, China and Rockville, Md. – August 29, 2011 – Synutra International, Inc. (NASDAQ: SYUT), a leading infant formula company in China and a producer, marketer and seller of nutritional products for infants, children and adults, today announced Donghao Yang has resigned from his position as Chief Financial Office
August 12, 2011	10-Q/A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A Amendment No. 1 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A Amendment No. 1 x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2011 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission file number 001-33397 SY
August 11, 2011	EX-18	AMENDMENT NO. 1 TO REGISTRATION RIGHTS AGREEMENT Exhibit 18 EXECUTION VERSION AMENDMENT NO. 1 TO REGISTRATION RIGHTS AGREEMENT THIS AMENDMENT NO. 1 (this “Amendment”) to the Registration Rights Agreement dated as of April 23, 2008 (the “Registration Rights Agreement”) by and among Synutra International, Inc., a Delaware corporation (the “Company”), Beams Power Investment Limited, a company with limited liability registered under the BVI Business
August 11, 2011	EX-14	FORBEARANCE AGREEMENT Exhibit 14 EXECUTION VERSION FORBEARANCE AGREEMENT This FORBEARANCE AGREEMENT (this “Agreement”) is made as of August 10, 2011, by and between Beams Power Investment Limited, a company with limited liability registered under the BVI Business Companies Act, 2004 (as amended) of the British Virgin Islands (“Borrower”), and Warburg Pincus Private Equity IX, L.
August 11, 2011	EX-16	AMENDMENT NO. 1 TO SHARE PLEDGE AGREEMENT Exhibit 16 AMENDMENT NO. 1 TO SHARE PLEDGE AGREEMENT THIS AMENDMENT NO. 1 (this “Amendment”) to the Share Pledge Agreement dated as of April 23, 2008 (the “Share Pledge Agreement”) by and among Beams Power Investment Limited, a company with limited liability registered under the BVI Business Companies Act, 2004 (as amended) of the British Virgin Islands (the “Pledgor”), Warburg Pincus Private Equi
August 11, 2011	EX-19	DRAG-ALONG AGREEMENT Exhibit 19 EXECUTION VERSION DRAG-ALONG AGREEMENT This DRAG-ALONG AGREEMENT (this “Agreement”) is made as of August 10, 2011, by and between Beams Power Investment Limited, a company with limited liability registered under the BVI Business Companies Act, 2004 (as amended) of the British Virgin Islands (“Beams Power”), and Warburg Pincus Private Equity IX, L.
August 11, 2011	EX-15	BEAMS POWER INVESTMENT LIMITED RESTATED SENIOR EXCHANGEABLE NOTE Exhibit 15 EXECUTION VERSION THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS NOTE HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS.
August 11, 2011	EX-99.2	JOINT FILER INFORMATION Exhibit 99.2 Designated Filer: Warburg Pincus Private Equity IX, L.P. Issuer & Ticker Symbol: Synutra International, Inc. (SYUT) Date of Event Requiring Statement: August 10, 2011 JOINT FILER INFORMATION Joint Filers: 1. Name: Warburg Pincus IX LLC Address: c/o Warburg Pincus LLC 450 Lexington Avenue New York, NY 10017 2. Name: Warburg Pincus Partners LLC Address: c/o Warburg Pincus LLC 450 Lexing
August 11, 2011	EX-99.3	JOINT FILERS’ SIGNATURES Exhibit 99.3 Designated Filer: Warburg Pincus Private Equity IX, L.P. Issuer & Ticker Symbol: Synutra International, Inc. (SYUT) Date of Event Requiring Statement: August 10, 2011 JOINT FILERS’ SIGNATURES WARBURG PINCUS IX LLC By: Warburg Pincus Partners LLC, its sole member By: Warburg Pincus & Co., its managing member By: /s/ Scott A. Arenare Date: August 11, 2011 Name: Scott A. Arenare Title: P
August 11, 2011	EX-99.1	EXPLANATION OF RESPONSES Exhibit 99.1 Designated Filer: Warburg Pincus Private Equity IX, L.P. Issuer & Ticker Symbol: Synutra International, Inc. (SYUT) Date of Event Requiring Statement: August 10, 2011 EXPLANATION OF RESPONSES (1) This Form 3 is filed on behalf of Warburg Pincus Private Equity IX, L.P., a Delaware limited partnership (“WP IX”), Warburg Pincus IX LLC, a New York limited liability company (“WP IX LLC”),
August 11, 2011	EX-17	AMENDMENT NO. 2 TO SHARE PLEDGE AGREEMENT Exhibit 17 EXECUTION VERSION AMENDMENT NO. 2 TO SHARE PLEDGE AGREEMENT THIS AMENDMENT NO. 2 (this “Amendment”) to the Share Pledge Agreement dated as of April 23, 2008 by and among Beams Power Investment Limited, a company with limited liability registered under the BVI Business Companies Act, 2004 (as amended) of the British Virgin Islands (the “Pledgor”), Warburg Pincus Private Equity IX, L.P. (
August 11, 2011	SC 13D/A	UNITED STATES UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A Under the Securities Exchange Act of 1934 (Amendment No. 5)* SYNUTRA INTERNATIONAL, INC. (Name of Issuer) Common Stock, Par Value $0.0001 Per Share (Title of Class of Securities) 87164C 10 2 (CUSIP Number) Scott A. Arenare, Esq. Managing Director and General Counsel Warburg Pincus LLC 450 Lexington Avenue New Yo
August 9, 2011	EX-99.1	Synutra Reports First Quarter Fiscal 2012 Financial Results Branded Formula Sales Demonstrate Sustained Recovery 1Q12 Formula Sales were $40.2 million 1Q12 Gross Margin Rose to 36.7% EXHIBIT 99.1 FOR IMMEDIATE RELEASE: Synutra Reports First Quarter Fiscal 2012 Financial Results Branded Formula Sales Demonstrate Sustained Recovery 1Q12 Formula Sales were $40.2 million 1Q12 Gross Margin Rose to 36.7% Qingdao, China and Rockville, Md. – August 9, 2011 – Synutra International, Inc. (NASDAQ: SYUT), a leading infant formula company in China and a producer, marketer and seller of nut
August 9, 2011	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2011 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission file number 001-33397 SYNUTRA INTERNATIONA
August 9, 2011	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): August 9, 2011 SYNUTRA INTERNATIONAL, INC.
August 2, 2011	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): August 2, 2011 SYNUTRA INTERNATIONAL, INC.
August 2, 2011	EX-99.1	Synutra Comments on its First Quarter of Fiscal 2012 Earnings Release Scheduled for August 9, 2011 EX-99.1 2 dp25556ex9901.htm EXHIBIT 99.1 EXHIBIT 99.1 FOR IMMEDIATE RELEASE: Synutra Comments on its First Quarter of Fiscal 2012 Earnings Release Scheduled for August 9, 2011 Qingdao, China and Rockville, Md. – August 2, 2011 – Synutra International, Inc. (NASDAQ: SYUT), a leading infant formula company in China and a producer, marketer and seller of nutritional products for infants, children and
June 14, 2011	EX-21.1	Subsidiary EXHIBIT 21.1 Subsidiaries of Synutra International, Inc. Subsidiary Jurisdiction Synutra, Inc. Illinois Shengyuan Nutritional Food Co., Ltd. China Heilongjiang Mingshan Dairy Co., Ltd., previously known as Luobei Shengyuan Dairy Co., Ltd. China Zhangjiakou Chahaer Dairy Co., Ltd., previously known as Zhangjiakou Shengyuan Dairy Co., Ltd. China Inner Mongolia Huiliduo Food Co., Ltd., previously kno
June 14, 2011	10-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended March 31, 2011 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission file number 000-50601 SYNUTRA INTERNATIONAL, INC.
June 14, 2011	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): June 14, 2011 SYNUTRA INTERNATIONAL, INC.
June 14, 2011	EX-99.1	Synutra Reports Fourth Quarter and Full Year Fiscal 2011 Financial Results Inventory Trends Reflect Sustained Recovery 4Q11 Net Sales Up 79.3% from 3Q11 Fiscal 2011 Gross Margin Increased to 31.3% EXHIBIT 99.1 FOR IMMEDIATE RELEASE: Synutra Reports Fourth Quarter and Full Year Fiscal 2011 Financial Results Inventory Trends Reflect Sustained Recovery 4Q11 Net Sales Up 79.3% from 3Q11 Fiscal 2011 Gross Margin Increased to 31.3% Qingdao, China and Rockville, Md. – June 14, 2011 – Synutra International, Inc. (NASDAQ: SYUT), a leading infant formula company in China and a producer, marketer and
June 14, 2011	EX-12.1	SYNUTRA INTERNATIONAL, INC. COMPUTATION OF RATIO OF EARNINGS TO FIXED CHARGES EXHIBIT 12.1 SYNUTRA INTERNATIONAL, INC. COMPUTATION OF RATIO OF EARNINGS TO FIXED CHARGES Year Ended March 31, 2011 2010 2009 2008 2007 (In thousands, except ratios) Fixed charges: Interest expense $ 10,321 $ 8,603 $ 4,857 $ 6,354 $ 1,896 Capitalized interest — 346 1,424 848 726 Estimation of the interest within rental expense 411 500 468 163 105 Total fixed charges $ 10,732 $ 9,449 $ 6,749 $ 7,3
May 9, 2011	SC 13D/A	UNITED STATES UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A Under the Securities Exchange Act of 1934 (Amendment No. 4)* SYNUTRA INTERNATIONAL, INC. (Name of Issuer) Common Stock, Par Value $0.0001 Per Share (Title of Class of Securities) 87164C 10 2 (CUSIP Number) Scott A. Arenare, Esq. Managing Director and General Counsel Warburg Pincus LLC 450 Lexington Avenue New Yo
April 26, 2011	EX-13	JOINT FILING AGREEMENT EXHIBIT 13 JOINT FILING AGREEMENT THIS JOINT FILING AGREEMENT is entered into as of April 26, 2011, by and among the parties signatories hereto.
April 26, 2011	SC 13D/A	UNITED STATES UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A Under the Securities Exchange Act of 1934 (Amendment No. 3)* SYNUTRA INTERNATIONAL, INC. (Name of Issuer) Common Stock, Par Value $0.0001 Per Share (Title of Class of Securities) 87164C 10 2 (CUSIP Number) Scott A. Arenare, Esq. Managing Director and General Counsel Warburg Pincus LLC 450 Lexington Avenue New Yo
February 24, 2011	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): February 18, 2011 SYNUTRA INTERNA UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): February 18, 2011 SYNUTRA INTERNATIONAL, INC. (Exact Name of Registrant as Specified in Charter) Delaware (State of Incorporation) 00-33397 13-4306188 (Commission File Number) (I.R.S.
February 3, 2011	EX-99.1	Synutra Reports Third Quarter Fiscal 2011 Financial Results Monthly Analysis of 3Q11 Illustrates Initial Recovery EXHIBIT 99.1 FOR IMMEDIATE RELEASE: Synutra Reports Third Quarter Fiscal 2011 Financial Results Monthly Analysis of 3Q11 Illustrates Initial Recovery Qingdao, China and Rockville, Md. – February 3, 2011 – Synutra International, Inc. (NASDAQ: SYUT), a leading infant formula company in China and a producer, marketer and seller of nutritional products for infants, children and adults, today announced
February 3, 2011	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2010 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission file number 001-33397 SYNUTRA INTERNAT
February 3, 2011	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): February 3, 2011 SYNUTRA INTERNATIONAL, INC.
January 7, 2011	DEFA14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(A) OF THE SECURITIES EXCHANGE ACT OF 1934 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(A) OF THE SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant x Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, For Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) o Definitive Proxy State
January 7, 2011	DEF 14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(A) OF THE SECURITIES EXCHANGE ACT OF 1934 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(A) OF THE SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant x Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, For Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) x Definitive Proxy State
November 4, 2010	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): November 4, 2010 SYNUTRA INTERNATIONAL, INC.
November 4, 2010	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2010 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission file number 001-33397 SYNUTRA INTERNA
November 4, 2010	EX-99.1	Synutra Reports Second Quarter and First Half Fiscal 2011 Financial Results 2Q11 Net Sales of $41.2 Million 2Q11 Net Loss of $21.2 Million, or $0.37 per Diluted Share EXHIBIT 99.1 FOR IMMEDIATE RELEASE: Synutra Reports Second Quarter and First Half Fiscal 2011 Financial Results 2Q11 Net Sales of $41.2 Million 2Q11 Net Loss of $21.2 Million, or $0.37 per Diluted Share Qingdao, China and Rockville, Md. – November 4, 2010 – Synutra International, Inc. (NASDAQ: SYUT), a leading infant formula company in China and a producer, marketer and seller of nutritional produ
September 9, 2010	EX-99.1	Synutra Announces Board Director Resignation -- Resignation Avoids Potential Conflict of Interest -- EXHIBIT 99.1 FOR IMMEDIATE RELEASE: Synutra Announces Board Director Resignation - Resignation Avoids Potential Conflict of Interest - Qingdao, China and Rockville, Md. – September 8, 2010 – Synutra International, Inc. (NASDAQ: SYUT), a leading infant formula company in China and a producer, marketer and seller of nutritional products for infants, children and adults, today announced that Mr. Ka K
September 9, 2010	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): September 3, 2010 SYNUTRA INTERNATIONAL, INC.
August 9, 2010	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2010 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission file number 001-33397 SYNUTRA INTERNATIONA
August 9, 2010	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): August 9, 2010 SYNUTRA INTERNATIONAL, INC.
August 9, 2010	EX-99.1	Synutra Reports First Quarter 2011 Financial Results 1Q11 Net Sales Up 77.0% to $83.8 Million from the Prior Year Period 1Q11 Net Income of $10.1 Million, or $0.19 per Diluted Share Exhibit 99.1 FOR IMMEDIATE RELEASE: Synutra Reports First Quarter 2011 Financial Results 1Q11 Net Sales Up 77.0% to $83.8 Million from the Prior Year Period 1Q11 Net Income of $10.1 Million, or $0.19 per Diluted Share Qingdao, China and Rockville, Md. – August 9, 2010 - Synutra International, Inc. (NASDAQ: SYUT), a leading infant formula company in China and a producer, marketer and seller of nutr
June 30, 2010	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): June 25, 2010 SYNUTRA INTERNATIONAL, INC.
June 30, 2010	EX-1.1	3,300,000 Shares Exhibit 1.1 3,300,000 Shares SYNUTRA INTERNATIONAL, INC. Common Stock (par value US$0.0001 per share) EQUITY UNDERWRITING AGREEMENT June 25, 2010 OPPENHEIMER & CO. INC. 300 MADISION AVENUE NEW YORK, NY 10017 USA ROTH CAPITAL PARTNERS, LLC 24 CORPORATE PLAZA NEWPORT BEACH, CA 92660 USA As Representatives of the several Underwriters named in Schedule I attached hereto. Ladies and Gentlemen: Synutra
June 25, 2010	424B2	Prospectus Supplement (To Prospectus dated May 12, 2010) 3,300,000 Shares Synutra International, Inc. Common Stock Form 424(B)(2) Filed Pursuant to Rule 424(b)(2) Registration Statement No: 333-163677 Prospectus Supplement (To Prospectus dated May 12, 2010) 3,300,000 Shares Synutra International, Inc.
June 24, 2010	424B5	Subject to Completion, dated June 24, 2010 Preliminary Prospectus Supplement (To Prospectus dated May 12, 2010) Synutra International, Inc. Common Stock Form 424(B)(5) The information in this preliminary prospectus supplement and the accompanying prospectus is not complete and may be changed.
June 9, 2010	EX-10.18	Business Operating Agreement EX-10.18 9 dp18094ex1018.htm EXHIBIT-10.18 EXHIBIT 10.18 Business Operating Agreement The business operating agreement (hereinafter “this agreement”) is entered into between the following Parties (hereinafter “the parties to this agreement”) on July 20th, 2008 in Qingdao, China. Party A: Shengyuan Nutritional Food Co., Ltd. Address: Party B: Address: Beijing Shengyuan Huimin Technology Service Co.
June 9, 2010	10-K	UNITED STATES UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended March 31, 2010 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission file number 000-50601 SYNUTRA INTERNATIONAL, INC.
June 9, 2010	EX-10.17	Exclusive Consulting and Service Agreement EXHIBIT 10.17 Exclusive Consulting and Service Agreement This Exclusive Consulting and Service Agreement (this “Agreement”) is entered into in Qingdao of China as of July 20, 2008 by and among the Following Parties: Party A: Shengyuan Nutritional Food Co., Ltd. Address: Party B: Beijing Shengyuan Huimin Technology Service Co., Ltd. Address: Whereas: 1. Validly existing and lawfully established wit
June 9, 2010	EX-21.1	Subsidiary EXHIBIT 21.1 Subsidiaries of Synutra International, Inc. Subsidiary Jurisdiction Synutra, Inc. Illinois Shengyuan Nutritional Food Co., Ltd. China Heilongjiang Mingshan Dairy Co., Ltd., previously known as Luobei Shengyuan Dairy Co., Ltd. China Zhangjiakou Shengyuan Dairy Co., Ltd. China Inner Mongolia Shengyuan Food Co., Ltd. China Meitek Technology (Qingdao) Co., Ltd., previously known as Mei Ta
June 9, 2010	EX-10.2	EMPLOYMENT AGREEMENT EX-10.2 5 dp18094ex1002.htm EXHIBIT-10.2 EXHIBIT 10.2 EMPLOYMENT AGREEMENT Party A (Employer) Name: Sheng Yuan Nutritional Food Co., Ltd., Beijing R&D Center Address: No. 106, Dongluyuan, Tongzhou District, Beijing Party B (Employee): Name: Weiguo Zhang Sex: Male ID Number: 452023247 (United States) Party A Name: Sheng Yuan Nutritional Food Co., Ltd., Beijing R&D Center Legal person: Liang Zhang A
June 9, 2010	EX-10.21	Share-holding Entrustment Agreement EXHIBIT 10.21 Share-holding Entrustment Agreement This entrustment agreement (hereinafter called as “this agreement”) was signed by following parties (hereinafter called as “agreement parties) in Qingdao, China on July 20, 2008. Party A: Shengyuan Nutritional Food Co., Ltd. (“Shengyuan Nutrition”) Address: Seashore Industrial Park, Jiaonan, Qingdao Natural person A: Jiang Yunpeng; ID card No.: 231
June 9, 2010	EX-10.4	EMPLOYMENT AGREEMENT EXHIBIT 10.4 EMPLOYMENT AGREEMENT Party A (Employer) Name: Sheng Yuan Nutritional Food Co., Ltd., Beijing R&D Center Address: No. 106, Dongluyuan, Tongzhou District, Beijing Party B (Employee): Name: Donghao Yang Sex: Male ID Number: 120104197109096836 Party A Name: Sheng Yuan Nutritional Food Co., Ltd., Beijing R&D Center Legal person: Liang Zhang Address: No. 106, Dongluyuan, Tongzhou District,
June 9, 2010	EX-10.1	EMPLOYMENT AGREEMENT EX-10.1 4 dp18094ex1001.htm EXHIBIT-10.1 EXHIBIT 10.1 EMPLOYMENT AGREEMENT Party A (Employer) Name: Sheng Yuan Nutritional Food Co., Ltd., Beijing R&D Center Address: No. 106, Dongluyuan, Tongzhou District, Beijing Party B (Employee): Name: Liang Zhang Sex: Male ID Number: 110106196002130076 Party A Name: Sheng Yuan Nutritional Food Co., Ltd., Beijing R&D Center Legal person: Xiuqing Meng Address:
June 9, 2010	EX-10.3	EMPLOYMENT AGREEMENT EXHIBIT 10.3 EMPLOYMENT AGREEMENT Party A (Employer) Name: Sheng Yuan Nutritional Food Co., Ltd., Beijing R&D Center Address: No. 106, Dongluyuan, Tongzhou District, Beijing Party B (Employee): Name: Joseph Chow Sex: Male ID Number: Party A Name: Sheng Yuan Nutritional Food Co., Ltd., Beijing R&D Center Legal person: Liang Zhang Address: No. 106, Dongluyuan, Tongzhou District, Beijing Party B: Nam
June 9, 2010	EX-99.1	Synutra Reports Financial Results for the Fourth Quarter and Full Year Fiscal 2010 4Q10 Net Sales Up 13.4% to $82.4 Million from the Prior Year Period 4Q10 Net Income of $9.1 Million, or $0.17 per Diluted Share EXHIBIT 99.1 FOR IMMEDIATE RELEASE: Synutra Reports Financial Results for the Fourth Quarter and Full Year Fiscal 2010 4Q10 Net Sales Up 13.4% to $82.4 Million from the Prior Year Period 4Q10 Net Income of $9.1 Million, or $0.17 per Diluted Share Qingdao, China and Rockville, Md. – June 9, 2010 - Synutra International, Inc. (NASDAQ: SYUT), a leading infant formula company in China and a producer,
June 9, 2010	EX-10.22	Share-holding Entrustment Agreement EXHIBIT 10.22 Share-holding Entrustment Agreement This Share-holding Entrustment Agreement (this “Agreement”) is entered into in of the People’s Republic of China (hereinafter “PRC”) as of July 20, 2008, by and among the following four Parties: Consignors: Natural person A: Yunpeng Jiang:a PRC citizen with ID card number: 231026196305045811 Natural person B: Jibin Zhang: a PRC citizen with ID card
June 9, 2010	EX-12.1	SYNUTRA INTERNATIONAL, INC. COMPUTATION OF RATIO OF EARNINGS TO FIXED CHARGES Organization chart EXHIBIT 12.1 SYNUTRA INTERNATIONAL, INC. COMPUTATION OF RATIO OF EARNINGS TO FIXED CHARGES Year Ended March 31, 2010 2009 2008 2007 2006 (In thousands, except ratios) Fixed charges: Interest expense $ 8,603 $ 4,857 $ 6,354 $ 1,896 $ 1,784 Capitalized interest 346 1,424 848 726 481 Estimation of the interest within rental expense 500 468 163 105 70 Total fixed charges $ 9,449 $ 6
June 9, 2010	EX-10.20	Share Pledge Agreement EX-10.20 11 dp18094ex1020.htm EXHIBIT-10.20 EXHIBIT 10.20 Share Pledge Agreement This Share Pledge Agreement (hereinafter referred to as “This Agreement”) was entered into in Qingdao, China, on July 20, 2008 by the following parties (hereinafter referred to as “Parties to the Agreement”): Party A: Shengyuan Nutritional Foods Co., Ltd. Address: Party B: Shareholder A: Zhang Jibin, ID No.: 370223196
June 9, 2010	EX-10.19	Equity Disposal Agreement EXHIBIT 10.19 Equity Disposal Agreement This Equity Disposal Agreement (the “Agreement”) is entered into in Qingdao of the People’s Republic of China as of July 20, 2008 by and among the following Parties (hereinafter “Parties of the Agreement”): Party A: Shengyuan Nutrition Food Co., Ltd. Address: Party B: Shareholder A: Zhang Jibin, ID card number: 370223196408110032 Address: Shareholder B: Jian
June 9, 2010	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): June 9, 2010 SYNUTRA INTERNATIONAL, INC.
May 11, 2010	CORRESP	Synutra International, Inc. Synutra International, Inc. 2275 Research Blvd., Suite 500 Rockville, MD 20850 U.S.A. 301-840-3888 301-838-0312 fax www.synutra.com VIA EDGAR AND FACSIMILE May 11, 2010 U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Attn: Mr. Norman Gholson, Attorney-Advisor Re: Synutra International, Inc. Registration Statement on Form S-3 (File N
May 4, 2010	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): May 4, 2010 SYNUTRA INTERNATIONAL, INC.
May 4, 2010	EX-99.1	Synutra Appoints Mr. Donghao Yang as Chief Financial Officer Mr. Joseph Chow to Serve on Board of Directors and in Ongoing Executive Advisory Role EXHIBIT 99.1 FOR IMMEDIATE RELEASE: Synutra Appoints Mr. Donghao Yang as Chief Financial Officer Mr. Joseph Chow to Serve on Board of Directors and in Ongoing Executive Advisory Role Qingdao, China and Rockville, Md. – May 4, 2010 - Synutra International, Inc. (NASDAQ: SYUT), a leading infant formula company in China and a producer, marketer and seller of nutritional products for infants, children
April 27, 2010	S-3/A	As filed with the Securities and Exchange Commission on April 27, 2010 As filed with the Securities and Exchange Commission on April 27, 2010 Registration No.
April 27, 2010	EX-12.1	SYNUTRA INTERNATIONAL, INC. COMPUTATION OF RATIO OF EARNINGS TO FIXED CHARGES (In thousands, except ratios) Exhibit 12.1 SYNUTRA INTERNATIONAL, INC. COMPUTATION OF RATIO OF EARNINGS TO FIXED CHARGES (In thousands, except ratios) Nine Months Ended December 31, Year Ended March 31, Three Months Ended March 31, Year Ended December 31, 2009 2009 2008 2007 2006 2005 2004 2004 Fixed charges: Interest expense $ 6,217 $ 4,857 $ 6,354 $ 1,896 $ 1,784 $ 183 $ 145 $ 638 Capitalized interest 346 1,424 848 726 481 6
April 8, 2010	RW	VIA EDGAR AND FACSIMILE VIA EDGAR AND FACSIMILE April 8, 2010 U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Attn: Mr. Norman Gholson, Attorney-Advisor Re: Synutra International, Inc. Registration Statement on Form S-3 (File No. 333-144983) Application for Withdrawal of Registration Statement Ladies and Gentlemen: Pursuant to Rule 477 promulgated under th

SYUT / Synutra International, Inc. - Depositi SEC, Relazione annuale, dichiarazione di delega

Statistiche di base

SEC Filings

SEC Filings (Chronological Order)